blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0781138

EP0781138 - LIPID ANALOGS FOR TREATING VIRAL INFECTIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.03.2009
Database last updated on 20.09.2024
Most recent event   Tooltip29.07.2011Lapse of the patent in a contracting state
New state(s): FR
published on 31.08.2011  [2011/35]
Applicant(s)For all designated states
WAKE FOREST UNIVERSITY
Medical Center Boulevard
Winston-Salem, NC 27157-1023 / US
For all designated states
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
300 Bynum Hall, Campus Box 4100
Chapel Hill, North Carolina 27599-4100 / US
[2008/21]
Former [1997/27]For all designated states
WAKE FOREST UNIVERSITY
Medical Center Boulevard
Winston-Salem, NC 27157-1023 / US
For all designated states
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
300 Bynum Hall, Campus Box 4100
Chapel Hill, North Carolina 27599-4100 / US
Inventor(s)01 / KUCERA, Louis S.
4860 Ellen Avenue
Pfafftown, NC 27040 / US
02 / MORRIS-NATSCHKE, Susan L.
1225 Martha's Chapel Road
Apex, NC 27502 / US
03 / ISHAQ, Khalid S.
105 Hunter Hill Place
Chapel Hill, NC 27514 / US
 [2006/37]
Former [1997/27]01 / KUCERA, Louis S.
4860 Ellen Avenue
Pfafftown, NC 27040 / US
02 / MORRIS-NATSCHKE, Susan L.
1225 Martha's chapel road
Apex, NC 27502 / US
03 / ISHAQ, Khalid S.
105 Hunter Hill Place
Chapel Hill, NC 27514 / US
Representative(s)Maiwald, Walter
Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[N/P]
Former [2008/39]Maiwald, Walter
Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3
80335 München / DE
Former [1999/32]Maiwald, Walter, Dr. Dipl.-Chem.
Maiwald GmbH, Postfach 33 05 23
80065 München / DE
Former [1997/27]Weber, Manfred, Dr.
c/o Boehringer Mannheim GmbH, Patentabteilung, Sandhoferstrasse 116
68298 Mannheim / DE
Application number, filing date95928365.607.08.1995
[1997/27]
WO1995US10111
Priority number, dateUS1994029741629.08.1994         Original published format: US 297416
US1994031490129.09.1994         Original published format: US 314901
[1997/27]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9606620
Date:07.03.1996
Language:EN
[1996/11]
Type: A2 Application without search report 
No.:EP0781138
Date:02.07.1997
Language:EN
The application published by WIPO in one of the EPO official languages on 07.03.1996 takes the place of the publication of the European patent application.
[1997/27]
Type: B1 Patent specification 
No.:EP0781138
Date:21.05.2008
Language:EN
[2008/21]
Search report(s)International search report - published on:EP13.06.1996
ClassificationIPC:A61K31/685, A61K31/675, C07F3/10, C07H19/10, C07H19/20, A61K31/66, A61K31/70, // A61P31/18
[2007/42]
CPC:
A61K31/685 (EP,US); A61K31/675 (EP,US); A61K31/7072 (EP,US);
A61K31/7076 (EP,US); A61P1/16 (EP); A61P31/00 (EP);
A61P31/12 (EP); A61P31/16 (EP); A61P31/18 (EP);
A61P31/20 (EP); A61P31/22 (EP); A61P35/00 (EP);
A61P43/00 (EP); C07F9/091 (EP,US); C07F9/10 (EP,US);
C07F9/106 (EP,US); C07F9/117 (EP,US); C07F9/65586 (EP,US);
C07F9/65616 (EP,US); C07H19/10 (EP,US); C07H19/20 (EP,US) (-)
Former IPC [2002/33]A61K31/685, A61K31/675, C07F3/10, C07H19/10, C07H19/20, A61K31/66, A61K31/70
Former IPC [1997/27]A61K31/685, A61K31/675, C07F3/10, C07H19/10, C07H19/20
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1997/27]
TitleGerman:LIPID-ANALOGE ZUR BEHANDLUNG VON VIRALEN INFEKTIONEN[1997/27]
English:LIPID ANALOGS FOR TREATING VIRAL INFECTIONS[1997/27]
French:ANALOGUES DE LIPIDES POUR LE TRAITEMENT D'INFECTIONS VIRALES[1997/27]
Entry into regional phase25.03.1997National basic fee paid 
25.03.1997Designation fee(s) paid 
25.03.1997Examination fee paid 
Examination procedure27.03.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
25.03.1997Examination requested  [1997/27]
23.01.2001Despatch of a communication from the examining division (Time limit: M04)
02.04.2001Reply to a communication from the examining division
11.10.2001Despatch of a communication from the examining division (Time limit: M04)
29.10.2001Reply to a communication from the examining division
22.10.2004Despatch of a communication from the examining division (Time limit: M04)
22.02.2005Reply to a communication from the examining division
26.04.2005Despatch of a communication from the examining division (Time limit: M06)
26.10.2005Reply to a communication from the examining division
17.11.2005Despatch of a communication from the examining division (Time limit: M06)
17.05.2006Reply to a communication from the examining division
14.03.2007Date of oral proceedings
15.06.2007Despatch of a communication from the examining division (Time limit: M02)
15.06.2007Minutes of oral proceedings despatched
03.08.2007Reply to a communication from the examining division
01.10.2007Communication of intention to grant the patent
14.01.2008Fee for grant paid
14.01.2008Fee for publishing/printing paid
Divisional application(s)EP07016369.6  / EP1852121
Opposition(s)24.02.2009No opposition filed within time limit [2009/18]
Fees paidRenewal fee
23.07.1997Renewal fee patent year 03
27.07.1998Renewal fee patent year 04
04.08.1999Renewal fee patent year 05
07.08.2000Renewal fee patent year 06
27.08.2001Renewal fee patent year 07
30.08.2002Renewal fee patent year 08
27.08.2003Renewal fee patent year 09
30.08.2004Renewal fee patent year 10
12.08.2005Renewal fee patent year 11
14.08.2006Renewal fee patent year 12
14.08.2007Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT21.05.2008
BE21.05.2008
DK21.05.2008
IT21.05.2008
NL21.05.2008
IE07.08.2008
LU07.08.2008
GB21.08.2008
SE21.08.2008
GR22.08.2008
CH31.08.2008
LI31.08.2008
ES01.09.2008
FR01.09.2008
PT21.10.2008
[2011/35]
Former [2011/25]AT21.05.2008
BE21.05.2008
DK21.05.2008
IT21.05.2008
NL21.05.2008
IE07.08.2008
LU07.08.2008
GB21.08.2008
SE21.08.2008
GR22.08.2008
CH31.08.2008
LI31.08.2008
ES01.09.2008
PT21.10.2008
Former [2010/28]AT21.05.2008
BE21.05.2008
DK21.05.2008
IT21.05.2008
NL21.05.2008
IE07.08.2008
LU07.08.2008
GB21.08.2008
SE21.08.2008
CH31.08.2008
LI31.08.2008
ES01.09.2008
PT21.10.2008
Former [2010/05]AT21.05.2008
BE21.05.2008
DK21.05.2008
IT21.05.2008
NL21.05.2008
IE07.08.2008
GB21.08.2008
SE21.08.2008
CH31.08.2008
LI31.08.2008
ES01.09.2008
PT21.10.2008
Former [2009/30]AT21.05.2008
BE21.05.2008
DK21.05.2008
NL21.05.2008
SE21.08.2008
CH31.08.2008
LI31.08.2008
ES01.09.2008
PT21.10.2008
Former [2009/12]AT21.05.2008
BE21.05.2008
DK21.05.2008
NL21.05.2008
SE21.08.2008
ES01.09.2008
PT21.10.2008
Former [2009/08]AT21.05.2008
DK21.05.2008
NL21.05.2008
SE21.08.2008
ES01.09.2008
Former [2009/07]AT21.05.2008
NL21.05.2008
SE21.08.2008
ES01.09.2008
Former [2008/50]AT21.05.2008
NL21.05.2008
ES01.09.2008
Former [2008/47]ES01.09.2008
Cited inInternational search[XY]DE3934820  (BOEHRINGER MANNHEIM GMBH [DE]) [XY] 1-52,85-91,103 * page 2, line 50 - page 3, line 5 * * page 5, paragraph L *;
 [A]WO9109602  (BOEHRINGER MANNHEIM GMBH [DE]) [A] 1-20,35-40,45-72,85-91,103* the whole document *;
 [Y]DE4010228  (MUELLER WERNER E G PROF DR [DE], et al) [Y] 1-20,35-40,85-91 * claim 1 *
 [Y]  - "In vitro evaluation of phosphocholine and quaternary ammonium containing lipids as novel anti-HIV agents", J.MED.CHEM., vol. 34, no. 4, pages 1377 - 83 [Y] 103 * page 1377, column L, line 26 - line 38 *
 [YP]  - "Membrane interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp 120 binding to monoclonal antibody", AIDS RES. HUM. RETROVIRUSES, vol. 11, no. 6, pages 705 - 712 [YP] 1-52 * page 705 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.